论文信息 - Design and baseline characteristics of the AMPLITUDE‐O cardiovascular outcomes trial of efpeglenatide, a weekly glucagon‐like peptide‐1 receptor agonist - 字舞流文

Design and baseline characteristics of the AMPLITUDE‐O cardiovascular outcomes trial of efpeglenatide, a weekly glucagon‐like peptide‐1 receptor agonist

N. Sattar | J. Rosenstock | H. Gerstein | R. Pratley | S. Del Prato | K. Branch | N. Khurmi | C. Lam | Laura Heenan | L. Heenan